Nothing Found

Sorry, no posts matched your criteria

November 19, 2018: ABL Expands GMP Viral Vector Manufacturing Capacity with State-of-the-Art Facility Acquisition in Lyon, France
June 20, 2018: ABL EUROPE,THE PURCHASER OF ACCINOV
February 2018: ABL Europe Enters into a Collaboration for the GMP Manufacture of Hookipa Biotech’s Heterologous Viral Vector Immunotherapy Platform
January 2018: SillaJen and ABL Europe Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies
January 2018: ABL EUROPE’S GMP MANUFACTURING FACILITY FOR VIRAL VECTOR PRODUCTION: SARTORIUS STEDIM

Headquarter
4 Rue Laurent Fries,
67400 Illkirch-Graffenstaden
Phone: +33 3 88 55 10 00

Lyon Site
317, avenue Jean Jaurès,
FRANCE - 69007 LYON
Phone: +33 (0)4 37 28 73 00

Scroll to top

News